期刊文献+

口腔鳞癌中VEGF和PCNA的表达相关性研究

Study on the correlation of VEGF and PCNA expressions in oral squamous cell carcinoma
下载PDF
导出
摘要 目的运用免疫组化方法研究VEGF、PCNA在口腔鳞癌及正常组织中的表达及其相互关系。方法收集原发性口腔鳞癌病理切片标本34例,癌旁正常组织15例。运用免疫组化方法检测VEGF和PCNA在口腔鳞癌及正常组织中的表达水平。结果 VEGF与PCNA在口腔鳞癌中阳性表达率均高于癌旁正常组织,两者在口腔鳞癌中阳性表达率与病理分级呈正相关关系。结论 VEGF和PCNA在口腔鳞癌中的表达存在相关性。检测VEGF和PCNA在口腔鳞癌组织中的表达水平对口腔鳞癌的病理分级的判断具有一定意义。 Objective To study the correlation of VEGF and PCNA expressions in oral squamous carcinoma and normal tis‐sues by immunohistochemical staining method .Methods 34 pathological samples of primary oral quamous cell carcinoma and 15 samples of normal tissues were collected .Immunohistochemically staining method was used to detect the expression of VEGF and PCNA .Results The positive rates of VEGF and PCNA in oral squamous carcinoma were higher than that of normal tis‐sue ,and the positive rate was positively correlated with pathological degrees .Conclusions The VEGF level was correlated with PCNA in oral squamous cell carcinoma .The tests of VEGF and PCNA may have significances in defining the pathological de‐gree of oral squamous cell carcinoma .
作者 成洲
出处 《滨州医学院学报》 2014年第5期352-354,共3页 Journal of Binzhou Medical University
关键词 鳞状细胞 血管内皮生长因子 增殖细胞核抗原 病理学分级 carcinoma, squamous cell, vascular epithelial growth factor, proliferating cell nuclear antigen, pathological degrees
  • 相关文献

参考文献12

  • 1Funakoshi T,CH Lee,JJ Hsieh. A systematic review of predic- tive and prognostic hiomarkers for VEGF-targeted therapy in re- nal ceil carcinoma[J]. Cancer Treat Rev, 2014,40 (4) : 533-547.
  • 2Sharma T,Dhingra R,Singh S,et al. Aflibereept: a novel VEGF targeted agent to explore the future perspectives of anti-anglo- genie therapy for the treatment of multiple tumors[J]. Mini Rev Med Chem,2013,13(4) :530-540.
  • 3Zhang W, Qin Z, Zhang X, et al. Roles of sequential ubiquitina- tion of PCNA in DNA-damage tolerance[J]. FEBS Lett, 2011, 585(18) :2786-2794.
  • 4Carmeliet P. VEGF as a key mediator of angiogenesis in cancer [J]. Oncology,2005,69 (Suppl 3) :4-10.
  • 5Ferrara N. VEGF as a therapeutic target in cancer[J]. Oncology, 2005, 69 (Suppl 3):11-16.
  • 6Glade-Bender J ,JJ Kandel,DJ Yamashiro. VEGF blocking thera- py in the treatment of cancer[J]. Expert Opin Biol Ther, 2003, 3 (2) :263-276. S.
  • 7hinkaruk S, Bayle M, Lain G, et al. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemo- therapy[J]. Curr Med Chem Anticancer Agents, 2003,3 (2) : 95- 117.
  • 8Kamba T,DM McDonald. Mechanisms of adverse effects of anti- VEGF therapy for cancer[J]. Br J Cancer, 2007,96 (12) : 1788- 1795.
  • 9Bagri A, Kouros-Mehr H, Leong KG, et al. Use of anti-VEGF adjuvant therapy in cancer: challenges and rationalel-J]. Trends Mol Med, 2010,16(3) : 122-132.
  • 10Dieckman LM, BD Freudenthal, MT Washington. PCNA struc- ture and function: insights from structures of PCNA complexes and post-translationally modified PCNA[J]. Suhcell Biochem, 2012,62(3) :281-299.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部